These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38082170)
1. Clinical Effectiveness of Preoperative 18F-FDG PET/CT in Predicting Pathological Tumor Grade in Patients with Pseudomyxoma Peritonei Originating from Appendix: A Retrospective Cohort Study. Aso K; Gohda Y; Hotta M; Minamimoto R; Shimizu Y; Uemura Y; Yano H Ann Surg Oncol; 2024 Mar; 31(3):1990-1995. PubMed ID: 38082170 [TBL] [Abstract][Full Text] [Related]
2. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei. Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878 [TBL] [Abstract][Full Text] [Related]
3. Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction. Passot G; Glehen O; Pellet O; Isaac S; Tychyj C; Mohamed F; Giammarile F; Gilly FN; Cotte E Eur J Surg Oncol; 2010 Mar; 36(3):315-23. PubMed ID: 19818580 [TBL] [Abstract][Full Text] [Related]
4. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei. Dubreuil J; Giammarile F; Rousset P; Bakrin N; Passot G; Isaac S; Glehen O; Skanjeti A Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1630-7. PubMed ID: 26907364 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei. Flood MP; Kong JC; Pham T; Waters PS; Soucisse M; Ramsay R; Wong HL; Mitchell C; Michael M; McCormick JJ; Warrier SK; Akhurst T; Heriot AG Eur J Surg Oncol; 2022 Jul; 48(7):1606-1613. PubMed ID: 35148916 [TBL] [Abstract][Full Text] [Related]
6. Liu S; Feng Z; Wen H; Jiang Z; Pan H; Deng Y; Zhang L; Ju X; Chen X; Wu X Jpn J Radiol; 2018 Sep; 36(9):544-550. PubMed ID: 29943313 [TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
8. Molecular insights and the role of 18F-FDG-PET/CT in the diagnosis of spinal gliomas. Nagashima Y; Nishimura Y; Eguchi K; Yamaguchi J; Haimoto S; Ohka F; Motomura K; Abe T; Matsuo M; Tsukamoto E; Hara M; Saito R Acta Neurochir (Wien); 2024 Mar; 166(1):154. PubMed ID: 38538929 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance and prognostic value of preoperative Chen S; Zhao Y; Tang Q; Wu C; Wang A; Ma L; Zhang X; Chen J; Gao Y; Liao X; Feng N; Fan Y; Zhang J; Li X; Liu M Cancer Imaging; 2022 Nov; 22(1):65. PubMed ID: 36435856 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma. Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975 [TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction of the pathological stage of advanced gastric cancer by Yamada K; Urakawa N; Kanaji S; Hasegawa H; Yamamoto M; Yamashita K; Matsuda T; Oshikiri T; Suzuki S; Kakeji Y Sci Rep; 2022 Jul; 12(1):11370. PubMed ID: 35790785 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features. Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184 [TBL] [Abstract][Full Text] [Related]
13. Determining the Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission/Computed Tomography in Detecting Prosthetic Aortic Graft Infection. Mitra A; Pencharz D; Davis M; Wagner T Ann Vasc Surg; 2018 Nov; 53():78-85. PubMed ID: 30012456 [TBL] [Abstract][Full Text] [Related]
14. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers. Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348 [TBL] [Abstract][Full Text] [Related]
15. Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer. Jo JE; Kim JY; Lee SH; Kim S; Kang T Acta Radiol; 2015 Dec; 56(12):1463-70. PubMed ID: 25406431 [TBL] [Abstract][Full Text] [Related]
16. Normal patterns of 18F-FDG appendiceal uptake in children. Reavey HE; Alazraki AL; Simoneaux SF Pediatr Radiol; 2014 Apr; 44(4):398-402. PubMed ID: 24287869 [TBL] [Abstract][Full Text] [Related]
17. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer. Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811 [TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis. Li C; Lan X; Yuan H; Feng H; Xia X; Zhang Y Ann Nucl Med; 2014 Jun; 28(5):436-46. PubMed ID: 24623152 [TBL] [Abstract][Full Text] [Related]
19. Characterization of sacral chordoma and differential diagnosis from other sacral malignancy using [18F]FDG PET/CT. Lee DY; Kim YI; Ryu JS; Kim W Medicine (Baltimore); 2024 Apr; 103(14):e37678. PubMed ID: 38579025 [TBL] [Abstract][Full Text] [Related]
20. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients. Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]